VITAS Innovative Hospice Care(R) Names Christopher Rieder Senior Vice President and Chief Information Officer
...nology solutions, information management and business
processes. Prior to that position, Rieder served as vice president of
information technology for kos
Pharmaceuticals, where he built a customer-
centric IT division to improve the company's customer service operations.
"Chris's experience at th...
PacifiCare Capitulates to Latest Patient Revolt
The netroots protest and calls were organized by Eve Gittelson, an
influential health policy blogger who writes on Daily kos
as nyceve, and
many of the calls were the product of work by Ricky Colombo in his own
"This is an incredible turnaround generated by a ma...
Barr Reports GAAP Earnings of $1.18 Per Share for 2007 and $0.30 Per Share for the Fourth Quarter; Adjusted Earnings Were $3.16 Per Share for 2007 and $0.79 Per Share for the Fourth Quarter
...fenadine hydrochloride tablets from Teva, which began in September
2005, and lower income from the royalty earned under its April 2005
agreements with kos
Pharmaceuticals relating to the Niaspan(R) and
Advicor(R) cholesterol lowering agents. These declines were partially
offset by an increase in royaltie...
Amylin Pharmaceuticals Elects Adrian Adams to Board of Directors
...depth of experience." Mr. Adams currently serves as President and CEO of Sepracor, Inc. Prior
to this he was President and Chief Executive Officer of kos
from 2002 until the acquisition of the company by Abbott Laboratories in
December 2006. Mr. Adams has over 30 years of experience in b...
Ralf Rosskamp, M.D. Joins Biodel's Scientific Advisory Board
...tive Vice President of Research
and Development at kos
Pharmaceuticals, where he managed all research and
development activities until kos
was acquired by Abbott Laboratories. Dr.
Rosskamp's accomplishments at kos
include building an integrated research
Midwest life science stocks sizzle in a tepid first quarter
...nostics business to GE Healthcare while retaining its specialty molecular diagnostics business, and its recent acquisition of cardiovascular company kos
Baxter has showed increasing financial strength as the effects of the new management team and resulting reorganization a few year...